comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 21:05:44 - browse：76738

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Chemotherapy shortages won’t get better under Biden’s latest plan

focus

WSS

Congenital heart disease patients face new threat of heart failure

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

An innovative path out of biotech’s “valley of death”

The woman behind the Dana Farber

Where are patients getting their prescriptions for GLP

focus

comprehensive

hotspot

Peter Hotez and the public health issue of online harassment

Congenital heart disease patients face new threat of heart failure

At least 13 dead in Texas as scorching temps continue

Timeline: Special counsel's investigation into Trump's handling of classified documents

As demand for Covid shots wanes, Moderna seeks its next success

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Virginia high school admissions case could be legal follow

Chemotherapy shortages won’t get better under Biden’s latest plan

Walensky prepares to leave CDC — and Congress — behind

Supreme Court wrestles with OxyContin maker's bankruptcy deal

entertainment

Kim Kardashian sparks debate on benefits of full

In diabetes hearing, Sanders takes on a new foe: food makers

Target recalls 2.2 million additional candles due to laceration, burn hazards

Spinal cord stimulation reduces pain in amputees, study finds

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

leisure time

focus

Wikipedia

Wikipedia